Article
Relative contributions of the ERG11VF125AL and MRR1AN647T mutations to fluconazole resistance in Clade III Candidozyma (Candida) auris clinical isolates.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases - 1 Feb 2026
Barker Katherine S, Zhang Qing, Peters Tracy L, Rybak Jeffrey M, Morschhäuser Joachim, Cuomo Christina A, Rogers P David
Abstract excerpt
OBJECTIVES: Candidozyma (Candida) auris is an emerging fungal pathogen of global concern that often exhibits multidrug resistance. Of the six described C. auris clades, Clade III has been found to be nearly universally fluconazole resistant, and almost every Clade III isolate described carries a mutation leading to a VF125AL substitution in ERG11, the gene encoding the fluconazole target lanosterol...
Read the complete abstract on PubMedTopics
- Fluconazole
- Antifungal Agents
- Drug Resistance, Fungal
- Humans
- Microbial Sensitivity Tests
